No Data
No Data
ALS Therapy Market Seen Increasing to Nearly $1.3B by 2029
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity Under Strategic Partnership With Pfizer
Flagship Pioneering and ProFound Therapeutics, a Flagship-founded company pioneering the expanded human proteome to develop novel medicines for a...
Denali Therapeutics(DNLI.US) Director Sells US$31,682.34 in Common Stock
$Denali Therapeutics(DNLI.US)$ Director Cook Jennifer E. sold 1,458 shares of common stock on Jun 6, 2024 at an average price of $21.73 for a total value of $31,682.34.Source: Announcement What is sta
Companies Like Denali Therapeutics (NASDAQ:DNLI) Are In A Position To Invest In Growth
Why Is Denali Therapeutics (DNLI) Up 15.6% Since Last Earnings Report?
B.Riley Financial Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $36
B.Riley Financial analyst Mayank Mamtani maintains $Denali Therapeutics(DNLI.US)$ with a buy rating, and maintains the target price at $36.According to TipRanks data, the analyst has a success rate of